Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
CAPS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.58 - $16.18
Previous CloseN/A
Volume2.10K
Average Volume (3M)795.35K
Market Cap
$9.65M
Enterprise Value$20.12M
Total Cash (Recent Filing)$1.74M
Total Debt (Recent Filing)$12.21M
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Aug 19, 2025EPS Estimate
-0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,190,251
10 Day Avg. Volume34,146
30 Day Avg. Volume795,345
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)0.36
Price to Sales (P/S)0.00
P/FCF Ratio3.41
Enterprise Value/Market Cap2.08
Enterprise Value/Revenue0.11
Enterprise Value/Gross Profit2.19
Enterprise Value/Ebitda-4.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Capstone Therapeutics News
PremiumCompany Announcements
Capstone Holding Corp. Expands Toro Stone Brand Nationwide
PremiumCompany Announcements
Capstone Therapeutics Announces Follow-On Public OfferingOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.21% Other Institutional Investors
99.79% Public Companies and
Individual Investors
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $1.58 and its highest was $16.18 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Capstone Therapeutics Corp’s market cap is $9.65M.
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is Aug 19, 2025 which is in 70 days.
How were Capstone Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Capstone Therapeutics Corp overvalued?
According to Wall Street analysts Capstone Therapeutics Corp’s price is currently Overvalued.
Does Capstone Therapeutics Corp pay dividends?
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate is -0.07.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 5,190,251 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
Company Description
Capstone Therapeutics Corp
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.